Green Alpha Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,888
Closed -$293K 110
2025
Q4
$293K Buy
+2,888
New +$232K 0.27% 89
2025
Q1
Sell
-3,618
Closed -$203K 126
2024
Q4
$203K Sell
3,618
-446
-11% -$27.8K 0.16% 125
2024
Q3
$277K Buy
+4,064
New +$229K 0.22% 115
2024
Q2
Sell
-4,469
Closed -$309K 140
2024
Q1
$309K Buy
4,469
+21
+0.5% +$1.33K 0.22% 120
2023
Q4
$329K Sell
4,448
-445
-9% -$29.2K 0.24% 128
2023
Q3
$334K Buy
4,893
+165
+3% +$14K 0.26% 119
2023
Q2
$444K Sell
4,728
-440
-9% -$34.3K 0.29% 115
2023
Q1
$350K Sell
5,168
-204
-4% -$13.1K 0.25% 122
2022
Q4
$266K Buy
+5,372
New +$219K 0.22% 124
2022
Q3
Sell
-5,383
Closed -$212K 145
2022
Q2
$212K Buy
5,383
+307
+6% +$16.4K 0.05% 145
2022
Q1
$355K Buy
5,076
+481
+10% +$35.2K 0.24% 119
2021
Q4
$358K Sell
4,595
-463
-9% -$40.9K 0.24% 118
2021
Q3
$483K Buy
5,058
+702
+16% +$74.1K 0.33% 117
2021
Q2
$541K Buy
4,356
+1,659
+62% +$198K 0.37% 115
2021
Q1
$355K Buy
+2,697
New +$369K 0.35% 93

Other funds holding EXAS

Green Alpha Advisors's EXAS Position: Q1 2026 in Review

Green Alpha Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2,888 shares — an estimated $293K sold.

Green Alpha Advisors first reported a position in EXAS in Q1 2021 and held it in 15 quarters. The position peaked at $541K in Q2 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Green Alpha Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Green Alpha Advisors sold 2,888 Exact Sciences shares in Q1 2026, an estimated $293K.
  • Green Alpha Advisors first reported a position in Exact Sciences in Q1 2021 and held it in 15 quarters.
  • Green Alpha Advisors's Exact Sciences position peaked at $541K in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Green Alpha Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.